SAN ANTONIO and CAMBRIDGE, Mass., Jan. 9, 2025 /PRNewswire/ — Owl Therapeutics (“Owl”), a biopharmaceutical company developing drugs to supercharge microglia, the immune cells of the brain, announces that Chief Executive Officer William E. Haskins, Ph.D. will present Owl’s latest…